Further results of ChIP assays revealed that SNHG22 could recruit EZH2 to the promoter regions of multiple tumor suppressor genes (E-cadherin, EAF2, ADRB2, rap1GAP and RUNX3), and modulating H3K27me3 levels to repress their transcription. This evidence concerns the gene SNHG22 and neoplasm.